Powered by Ajaxy


Friday Charts: Economic Sentiment Reaches Record High

By Louis Basenese - Mar 17, 2017

Optimism can be a powerful economic force. That is, as long as all the good feelings translate into good actions. Like increased capital expenditures and hiring. Well, economic sentiment has never been higher.

Friday Charts

Friday Charts: Boom and Bust IPOs, Artificial Intelligence and an Ominous Divergence

By Louis Basenese - Mar 3, 2017

This week, Louis Basenese covers the problem with tech IPOs, the proliferation of artificial intelligence and a rare and potentially ominous divergence between stocks and bonds.

Smart Phones

Why the No. 1 Way to Play the iPhone Isn’t Apple

By Jonathan Rodriguez - Feb 23, 2017

Most investors in the IoT space are on the hunt for a technology company that’s crafting the world’s next game-changing device. But you don’t need to isolate a single winner like Apple. There’s a way to cash in no matter who cracks the code.

Friday Charts

Death by Disruption for BlackBerry, Twitter… and Humans?!

By Louis Basenese - Feb 17, 2017

The latest data out of tech research firm Gartner confirm the most obvious, overdue and unsurprising death in the history of tech.


Uptick in Police Surveillance Tech Sparks New Opportunity

By Jonathan Rodriguez - Feb 16, 2017

One local government just paid a small fortune for a powerful spy tool. And the stock that owns the technology has generated 307% gains since 2012.


The Hidden Story Behind Apple Earnings Announcement

By Jonathan Rodriguez - Feb 9, 2017

Investors have already begun rotating their portfolios to shed large-cap tech holdings and load up on domestically focused names.

Friday Charts

Friday Charts: Apple Pops, the Death of Volatility, and Fitbit’s Tragic End

By Louis Basenese - Feb 3, 2017

We’re exploring Apple’s favorable iPhone news, Trump’s surprising effect on the market, and Fitbit’s continued death spiral.


Patent Filings: The Next Great Leading Indicator

By Louis Basenese - Feb 2, 2017

An uptick in patent filings has proven to be a reliable indication of new, potentially game-changing products in development. It’s also an earlier indicator of stock price performance.

Unicorn Stocks

Friday Charts: Unicorns, Hot IPOs and a Biotech Buyout Binge

By Louis Basenese - Jan 27, 2017

A picture can be worth a thousand words. Even for investors. So we’re going back to our roots – and letting a few carefully selected charts do the talking every Friday


How to Master the “Hype Cycle” for Maximum Profits

By Louis Basenese - Jan 26, 2017

This is one of the simplest, yet most powerful tools that you can use to pinpoint the next profit opportunities in technology stocks.


How Will We Stop the Rise of Superbugs?

By David Dittman - Jan 19, 2017

A Nevada woman is dead because of an infection that was able to fend off every available antibiotic in the United States. How the heck are we going to stop the rise of killer superbugs?


Gene Editing: CRISPR Patent Dispute Can’t Slow Innovation

By David Dittman - Jan 16, 2017

CRISPR-Cas9 is the big name in gene-editing technology — and for good reason. An ongoing patent dispute holds potentially millions — even billions — in new business. But researchers continue to find new ways to make us better, stronger, faster...